{"url_path":"/sec/bctx/8-k/2026-06-03/item-3-02","section_key":"item-3-02","section_title":"Item 3.02 Unregistered Sales of Equity Securities.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-03","source_url":"https://www.sec.gov/Archives/edgar/data/1610820/0001493152-26-026953-index.html","accession_number":"0001493152-26-026953","cik":"0001610820","ticker":"BCTX","issuer_name":"BriaCell Therapeutics Corp.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1610820/0001493152-26-026953-index.html","primary_entity_key":"0001610820","primary_entity_name":"BriaCell Therapeutics Corp."},"word_count":36,"has_tables":true,"body_markdown":"** **\n\n**Item\n3.02 Unregistered Sales of Equity Securities.**\n\n \n\nThe\ndisclosure set forth in Item 1.01 of this Current Report on Form 8-K regarding the Placement Agent Warrants and the shares issuable thereunder\nare hereby incorporated by reference."}